Analysis of Body Composition and Levels of Antimicrobial Peptides in Patients with Basal Cell Carcinoma: A Preliminary Study
- PMID: 39860425
- PMCID: PMC11765587
- DOI: 10.3390/jcm14020419
Analysis of Body Composition and Levels of Antimicrobial Peptides in Patients with Basal Cell Carcinoma: A Preliminary Study
Abstract
Background: Excessive body fatness is the basis of many diseases, especially civilization-related ones. The aim of this study is to analyze the body composition and serum levels of selected antimicrobial peptides (AMPs) in patients with basal cell carcinoma (BCC), in comparison to healthy controls (HCs), and investigate whether any specific parameter significantly increases the risk of BCC development. Methods: The body composition and measurements of serum levels of cathelicidin and human-beta-defensin-2 were analyzed in a group of 100 subjects (50 patients with BCC and 50 HCs). Results: There were statistically significant differences between the visceral fat rating (BCC 11.7 vs. control 10.1), cathelicidin (BCC 1022.6 vs. control 428.4), defensin-2 (BCC 1.2 vs. control 0.4), age (BCC 68.7 vs. control 62.4), and the visceral fat/muscle ratio (BCC 0.24 vs. control 0.21). Conclusions: It seems that excessive fat, especially visceral fat, may pose a risk of developing skin cancer. Therefore, it should be taken into account when caring for patients and they should be made aware that losing body weight may be important not only in reducing the risk of hypertension or diabetes but also cancer diseases. There are numerous well-known risk factors for developing skin cancer, but few are modifiable. Among these modifiable factors is the patient's weight and body composition, so improvaing lifestyle is crucial in the prevention of skin cancers.
Keywords: basal cell carcinoma; body composition; cathelicidin; defensin; skin; visceral fat.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Elevated serum levels of cathelicidin and β-defensin 2 are associated with basal cell carcinoma.Cent Eur J Immunol. 2021;46(3):360-364. doi: 10.5114/ceji.2021.109707. Epub 2021 Oct 6. Cent Eur J Immunol. 2021. PMID: 34764808 Free PMC article.
-
Correlations between antimicrobial peptides and spectrophotometric skin color parameters in patients with basal cell carcinoma.J Cancer Res Clin Oncol. 2023 Aug;149(9):5697-5704. doi: 10.1007/s00432-022-04530-z. Epub 2022 Dec 21. J Cancer Res Clin Oncol. 2023. PMID: 36542158 Free PMC article.
-
The role of TGF-β and antimicrobial peptides in basal cell carcinoma: a systematic review.Postepy Dermatol Alergol. 2023 Jun;40(3):384-389. doi: 10.5114/ada.2023.124747. Epub 2023 Feb 1. Postepy Dermatol Alergol. 2023. PMID: 37545828 Free PMC article. Review.
-
The Impact of Education Level on Basal Cell Carcinoma Development Risk.Cureus. 2024 Jun 6;16(6):e61827. doi: 10.7759/cureus.61827. eCollection 2024 Jun. Cureus. 2024. PMID: 38975452 Free PMC article.
-
Visceral adiposity and inflammatory bowel disease.Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9. Int J Colorectal Dis. 2021. PMID: 34104989 Review.
References
-
- Gómez-Ambrosi J., González-Crespo I., Catalán V., Rodríguez A., Moncada R., Valentí V., Romero S., Ramírez B., Silva C., Gil M.J., et al. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities. Clin. Nutr. 2018;37:580–589. doi: 10.1016/j.clnu.2017.01.010. - DOI - PubMed
LinkOut - more resources
Full Text Sources